A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416
NCT03283098
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Secondary Hyperparathyroidism
Interventions
DRUG:
Etelcalcetide
DRUG:
Placebo
Sponsor
Amgen